Pfizer’s RSV vaccine 82% effective against severe infection in infants, final data shows

[ad_1] Pfizer’s experimental respiratory syncytial virus (RSV) vaccine is 82 percent effective in preventing severe infections in babies when given to mothers in the second half of pregnancy, according to trial details published Wednesday that confirm preliminary data from the…








